BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8977665)

  • 1. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma.
    Jones SM; Mathew CM; Dixey J; Lovell CR; McHugh NJ
    Br J Dermatol; 1996 Nov; 135(5):678-86. PubMed ID: 8977665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
    Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
    J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
    Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of cutaneous delayed hypersensitivity reactions in nevus anemicus. Evidence for close concordance of cutaneous delayed hypersensitivity and endothelial E-selectin expression.
    Mizutani H; Ohyanagi S; Umeda Y; Shimizu M; Kupper TS
    Arch Dermatol; 1997 May; 133(5):617-20. PubMed ID: 9158415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
    Reefman E; Kuiper H; Limburg PC; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2008 Jan; 67(1):11-18. PubMed ID: 17502354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased transendothelial migration of scleroderma lymphocytes.
    Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
    Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of soluble adhesion molecules in systemic scleroderma].
    Alekperov RT; Timchenko AV; Aleksandrova EN; Samsonov MIu; Guseva NG; Nasonova EL
    Klin Med (Mosk); 2003; 81(10):43-7. PubMed ID: 14664174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.
    Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U
    J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease.
    Koch AE; Kronfeld-Harrington LB; Szekanecz Z; Cho MM; Haines GK; Harlow LA; Strieter RM; Kunkel SL; Massa MC; Barr WG
    Pathobiology; 1993; 61(5-6):239-46. PubMed ID: 7507681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients.
    Sais G; Vidaller A; Jucglá A; Condom E; Peyrí J
    Arch Dermatol; 1997 Apr; 133(4):443-50. PubMed ID: 9126007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of adhesion molecules in inflammation of the common bile duct in patients with secondary cholangitis due to biliary obstruction.
    Gulubova M; Vlaykova T; Manolova I; Hadjipetkov P; Popharitov A
    Hepatogastroenterology; 2008; 55(84):836-41. PubMed ID: 18705278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal expression of cell adhesion molecules in placentae from women with systemic lupus erythematosus and the antiphospholipid syndrome.
    Lakasing L; Campa JS; Parmar K; Poston R; Hunt BJ; Poston L
    Placenta; 2000; 21(2-3):142-9. PubMed ID: 10736236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
    Janssens AS; Lashley EE; Out-Luiting CJ; Willemze R; Pavel S; de Gruijl FR
    Exp Dermatol; 2005 Feb; 14(2):138-42. PubMed ID: 15679584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.